EUVIMEDEUVIMED entdecken
Crossref

The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

Surbhi Grover, Katie E Lichter, Anna Likhacheva, Joanne W Jang, Matthew S Ning, Tyler P Robin, William Small, Rajat J Kudchadker, Jamema Swamidas, Supriya Chopra, Bhavana Rai, Sunil Dutt Sharma und 13 weitere

Brachytherapy · 2023-11 · 22 (6) · 716-727

DOI: 10.1016/j.brachy.2023.07.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2023-11. Verfasst von Surbhi Grover und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA. Electronic address: Surbhi.Grover@pennmedicine.upenn.edu. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Genital Neoplasms, Female. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Government of South Australia, U.S. Department of Defense, Uniformed Services University of the Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings. METHODS AND MATERIALS: ABS and IBS members with expertise in brachytherapy formulated this consensus statement based on their collective clinical experience in LMICs with varying levels of resources. RESULTS: The ABS and IBS strongly encourage the establishment of HDR brachytherapy programs for the treatment of gynecological malignancies. With the consideration of resource variability in LMICs, we present 15 minimum component requirements for the establishment of such programs. Guidance on these components, including discussion of what is considered to be essential and what is considered to be optimal, is provided. CONCLUSIONS: This ABS/IBS consensus statement can guide the successful and safe establishment of HDR brachytherapy programs for gynecological malignancies in LMICs with varying levels of resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsGenital Neoplasms, FemaleFemaleHumansUnited StatesDeveloping CountriesRadiotherapy Dosage

Stichwörter der Autor:innen

BrachytherapyCervix cancerConsensus guidelinesGlobal oncologyImplementing new treatment techniquesPatient safetyResource-limited settingUterine cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA. Electronic address: Surbhi.Grover@pennmedicine.upenn.edu.
  • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA.
  • Department of Radiation Oncology, Sutter Health Sacramento, Sacramento, CA.
  • Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
  • Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO.

Förderung

  • Government of South Australia
  • U.S. Department of Defense
  • Uniformed Services University of the Health Sciences

Zitieren

APA

Grover, S., Lichter, K. E., Likhacheva, A., Jang, J. W., Ning, M. S., Robin, T. P., Small, W., Kudchadker, R. J., Swamidas, J., Chopra, S., Rai, B., Sharma, S. D., Sharma, D. N., Kuppusamy, T., Yang, R., Berger, D., Mendez, L. C., Glaser, S., Erickson, D. L., …, & Mahantshetty, U. (2023). The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy, 22(6), 716-727. https://doi.org/10.1016/j.brachy.2023.07.003

Vancouver

Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, et al. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 2023;22(6):716-727. doi:10.1016/j.brachy.2023.07.003

BibTeX
@article{Grover2023,
  author = {Grover, Surbhi and Lichter, Katie E and Likhacheva, Anna and Jang, Joanne W and Ning, Matthew S and Robin, Tyler P and Small, William and Kudchadker, Rajat J and Swamidas, Jamema and Chopra, Supriya and Rai, Bhavana and Sharma, Sunil Dutt and Sharma, Daya N and Kuppusamy, Thayalan and Yang, Ruijie and Berger, Daniel and Mendez, Lisbeth Cordero and Glaser, Scott and Erickson, Delnora L and Chino, Junzo and Mourtada, Firas and Abdel-Wahab, May and Jhingran, Anuja and Simonds, Hannah and Mahantshetty, Umesh},
  title = {The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries},
  journal = {Brachytherapy},
  year = {2023},
  volume = {22},
  number = {6},
  pages = {716--727},
  doi = {10.1016/j.brachy.2023.07.003}
}
Kostenlos starten →